VNRX Obtains $9.9M Convertible Note Waiver from Lind, Avoids Default, Preserves Conversion Option at 90% of VWAP
VolitionRx Limited · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · Now $2.65
-8.0% in 3d after detection
Post-detection moves
1h
-1.9%
1d
-4.5%
3d
-8.0%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS